PMID: 8610833Mar 1, 1996Paper

Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study

The American Journal of Psychiatry
D G DanielT S Williams

Abstract

The purpose of this study was to compare the side effect +profiles of clozapine and risperidone. The subjects were 20 outpatients with schizophrenia or schizoaffective disorder who were clinically stable on a regimen of clozapine at the time of screening. They underwent a randomized-order crossover comparison of 6 weeks of risperidone treatment and 6 weeks of clozapine treatment. Clinical and neurocognitive variables were assessed by raters blind to medication status, and severity of side effects was determined from patients' self-reports. Side effect measures, but not clinical ratings, were significantly different after 6 weeks of treatment with the two drugs. Patients required more benztropine for motor effects and complained of more insomnia with risperidone and more sedation with clozapine. Body weight was higher at the end of clozapine treatment than at the end of risperidone treatment. In this exploratory study, the side effect profiles of clozapine and risperidone were consistent with the different pharmacodynamic profiles of the two drugs.

Citations

Feb 8, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Emmanuel StipLuc Jean Boulay
Oct 28, 2014·Bipolar Disorders·Xian-Bin LiJose de Leon
Sep 12, 2006·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Canan Basar-ErogluChristina Schmiedt
Apr 7, 2005·Clinical and Experimental Pharmacology & Physiology·Miyuki OtaAkira Ota
Jan 5, 2002·CNS Drugs·Daniel TarsyFrank I Tarazi
Sep 22, 2005·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Peter FalkaiUNKNOWN WFSBP Task Force on Treatment Guidelines for Schizophrenia
Jun 30, 2005·Journal of Psychiatric Practice·Leslie CitromeJan Volavka
May 5, 2000·The Cochrane Database of Systematic Reviews·A TuunainenS M Gilbody
May 5, 2000·The Cochrane Database of Systematic Reviews·E KennedyS Gilbody
Nov 12, 2010·The Cochrane Database of Systematic Reviews·Claudia Asenjo LobosStefan Leucht
Jan 21, 2011·The Cochrane Database of Systematic Reviews·Katja KomossaStefan Leucht
Nov 4, 2005·European Archives of Psychiatry and Clinical Neuroscience·Michael RiedelHans-Jürgen Möller
Mar 30, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·C Stanniland, D Taylor
Sep 27, 2005·Brain : a Journal of Neurology·Garry D HoneyPaul C Fletcher
Feb 28, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·H J Möller
Feb 28, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·H J Möller
Nov 25, 2017·BMJ Case Reports·Liew Sat Lin ConstanceRajesh Kumar Muniandy
Mar 12, 1999·British Journal of Clinical Pharmacology·M CampbellS H Thomas
Jun 14, 2003·The Cochrane Database of Systematic Reviews·R H HunterF Song
Oct 9, 2002·Clinical and Experimental Pharmacology & Physiology·Miyuki OtaAkira Ota
Jan 1, 1996·Acta Psychiatrica Scandinavica. Supplementum·R L Borison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here